Literature DB >> 15570602

Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.

Ingrid J Castellanos1, Wasfi Al-Azzam, Kai Griebenow.   

Abstract

The effectiveness of the covalent modification of alpha-chymotrypsin with methoxy poly(ethylene glycol) (PEG) to afford its stabilization during encapsulation in poly(lactic-co-glycolic) acid (PLGA) microspheres by a solid-in-oil-in-water method was investigated. alpha-Chymotrypsin was chemically modified with PEG (M(w) = 5000) using molar ratios of PEG-to-chymotrypsin ranging from 0.4 to 96. Various conjugates were obtained and the amount of PEG modification was determined by capillary electrophoresis. In this investigation, only those conjugates with PEG/chymotrypsin molar ratios between approximately 1 and 8 were considered because higher levels of modification caused protein instability even before encapsulation. The stability and functionality of the chymotrypsin formulations were investigated before encapsulation by measuring enzyme kinetics, thermal stability, and tertiary structure intactness, and after the initial lyophilization process by determining the secondary structure content. These stability parameters were related to select ones after encapsulation in PLGA microspheres (specifically, the amount of insoluble aggregates, residual enzyme activity, and magnitude of protein structural perturbations). The results show that the more stable the protein conformation before encapsulation was, the higher was the retention of the specific activity after encapsulation. In contrast, no relationship was found between the protein stability before encapsulation and the magnitude of encapsulation-induced protein aggregation. Even the lowest level of modification (PEG-to-chymotrypsin molar ratio of 0.7) drastically reduced the amount of insoluble aggregates from 18% for the nonmodified protein to 4%. The results demonstrate that PEG modification was able to largely prevent chymotrypsin aggregation and activity loss upon solid-in-oil-in-water encapsulation in PLGA microspheres. It is demonstrated that it is essential to optimize the degree of protein modification to ascertain protein stability upon encapsulation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15570602     DOI: 10.1002/jps.20243

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

Review 1.  Injectable controlled release depots for large molecules.

Authors:  Steven P Schwendeman; Ronak B Shah; Brittany A Bailey; Anna S Schwendeman
Journal:  J Control Release       Date:  2014-06-12       Impact factor: 9.776

2.  Prevention of benzyl alcohol-induced aggregation of chymotrypsinogen by PEGylation.

Authors:  José A Rodríguez-Martínez; Izarys Rivera-Rivera; Kai Griebenow
Journal:  J Pharm Pharmacol       Date:  2011-05-03       Impact factor: 3.765

3.  Stabilization of alpha-chymotrypsin upon PEGylation correlates with reduced structural dynamics.

Authors:  José A Rodríguez-Martínez; Ricardo J Solá; Betzaida Castillo; Héctor R Cintrón-Colón; Izarys Rivera-Rivera; Gabriel Barletta; Kai Griebenow
Journal:  Biotechnol Bioeng       Date:  2008-12-15       Impact factor: 4.530

4.  Enzymatic activity and thermal stability of PEG-alpha-chymotrypsin conjugates.

Authors:  José A Rodríguez-Martínez; Izarys Rivera-Rivera; Ricardo J Solá; Kai Griebenow
Journal:  Biotechnol Lett       Date:  2009-02-18       Impact factor: 2.461

Review 5.  Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.

Authors:  Sheetal S Pai; Robert D Tilton; Todd M Przybycien
Journal:  AAPS J       Date:  2009-02-06       Impact factor: 4.009

6.  Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheres.

Authors:  Giselle M Flores-Fernández; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012

Review 7.  Methods to assess in vitro drug release from injectable polymeric particulate systems.

Authors:  Susan S D'Souza; Patrick P DeLuca
Journal:  Pharm Res       Date:  2006-01-13       Impact factor: 4.580

8.  Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres.

Authors:  Moraima Morales-Cruz; Giselle M Flores-Fernández; Myreisa Morales-Cruz; Elsie A Orellano; José A Rodriguez-Martinez; Mercedes Ruiz; Kai Griebenow
Journal:  Results Pharma Sci       Date:  2012

9.  Chemical glycosylation of cytochrome c improves physical and chemical protein stability.

Authors:  Yamixa Delgado; Moraima Morales-Cruz; José Hernández-Román; Yashira Martínez; Kai Griebenow
Journal:  BMC Biochem       Date:  2014-08-06       Impact factor: 4.059

Review 10.  Gluten Degrading Enzymes for Treatment of Celiac Disease.

Authors:  Guoxian Wei; Eva J Helmerhorst; Ghassan Darwish; Gabriel Blumenkranz; Detlef Schuppan
Journal:  Nutrients       Date:  2020-07-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.